定序試劑市場 - 全球產業規模、佔有率、趨勢、機會及預測（按技術、類型、應用、地區和競爭格局分類，2021-2031年）

全球定序試劑市場預計將從 2025 年的 95.7 億美元成長到 2031 年的 174.6 億美元，複合年成長率為 10.54%。

這些試劑包括必需酵素、化學試劑盒和耗材，是科研和臨床環境中樣品製備和核酸分析的必備材料。成長要素的主要因素是慢性病盛行率的上升以及由此產生的對基於精準基因組分析的精準醫療的需求。例如，美國癌症協會 (ACS) 估計，到 2025 年，美國將新增 2,041,910 例癌症病例，凸顯了先進診斷能力的緊迫感。日益加重的疾病負擔使得持續供應用於標靶治療選擇和突變檢測的高品質試劑變得至關重要。

然而，建構定序基礎設施所需的大量資本投入阻礙了市場擴張。許多小規模實驗室和機構，尤其是在新興經濟體，面臨購置和維護先進定序平台的高成本。這種經濟障礙直接限制了它們持續購買試劑的能力，從而有效地縮小了潛在市場。因此，高昂的進入門檻減緩了資源匱乏地區先進定序技術的全球普及，並降低了這些地區試劑消耗的整體潛力。

市場促進因素

次世代定序平台的技術進步是推動全球定序試劑市場發展的主要動力。高通量系統的引入降低了定序成本，同時提高了數據產量，從而產生了對流動池和樣品製備耗材的巨大需求。隨著實驗室轉向使用這些高通量儀器以提高效率，相關試劑的經常性收入也不斷增加。例如，牛津奈米孔技術公司（Oxford Nanopore Technologies）在2025年9月公佈，其PromethION產品系列上半年的收入為5,110萬英鎊。這一成長表明，平台創新正在推動大規模基因組分析所需的特殊化學試劑的持續消費。

同時，政府主導和基因組研究經費的激增，透過鼓勵進行大規模人群研究，推動了市場需求。公共和私人投資日益集中於泛基因組參考定序和精準醫療項目，這些項目高度依賴廣泛的定序工作流程。 2025年3月，加拿大基因組計劃啟動了加拿大精準醫療舉措，投資8,100萬美元用於建立多樣化的基因組數據資源。此外，根據News-Medical.Net報道，華盛頓大學醫學院於2025年接受1,400萬美元津貼，用於更新其人類泛基因組參考定序計劃。此類資金使研究機構能夠購買數千個樣本所需的耗材，確保市場持續成長。

市場挑戰

建構定序基礎設施所需的大量資本投入，對全球定序試劑市場的擴張構成了重大障礙。基因組平台的高成本，實際上阻礙了資源匱乏地區的小規模實驗室和研究機構進入該領域。由於試劑消耗量與定序儀的安裝數量密切相關，這些機構無法克服最初的資金障礙，直接限制了其持續的銷售量。缺乏購買必要硬體的預算，潛在客戶便無法產生對相關化學試劑盒和耗材的需求，限制了潛在市場的總規模。

科研經費的縮減進一步加劇了這種經濟壓力，而科研經費是臨床和學術機構購買重要設備的關鍵資金來源。根據美國醫學院協會統計，2025財政年度美國國立衛生研究院（NIH）撥給美國機構的科研津貼比上年度減少了約50億美元。這些大幅削減的經費限制了實驗室的購買力，迫使它們推遲基礎設施升級和擴建。因此，平台普及率的緩慢造成了下游瓶頸，並嚴重阻礙了定序試劑領域的銷售量成長。

市場趨勢

由於亟需揭示細胞異質性（而批量定序往往忽略了這一點），因此空間基因組學和單細胞耗材市場需求正呈指數級成長。研究人員擴大採用複雜的試劑組，這些試劑盒可以直接將基因表現映射到組織結構或對單一細胞進行條碼標記，但與標準樣品製備相比，這些工作流程的單樣本成本顯著更高。儘管資本設備銷售面臨波動，但這種向高解析度生物分析的轉變仍然支撐著試劑產業的收入成長。例如，10x Genomics 在 2025 年 1 月報告稱，儘管儀器銷售環境充滿挑戰，但其 2024 年全年耗材收入仍達到約 4.934 億美元，同比成長 3%。

同時，用於腫瘤譜分析和液態生物檢體的專用試劑開發構成了一個強勁且高需求的細分市場。實驗室正積極採購先進的化學試劑盒，用於超靈敏地檢測甲基化模式和循環腫瘤DNA (ctDNA)，這對於治療監測和非侵入性癌症篩檢至關重要。這些精準診斷流程需要高度最佳化的富集試劑盒和酵素來確保準確性，從而顯著增加了臨床醫生對試劑的重複訂購頻率。 Guardant Health在2025年2月發布的報告也印證了這一趨勢，報告顯示，2024年全年腫瘤臨床檢測量同比成長20%，達到約206,700例，直接推動了這些專用分子診斷耗材的消耗。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球定序試劑市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依技術分類（桑格定序、次世代定序、第三代定序）
  • 依類型（文庫試劑盒、模板試劑盒、對照試劑盒、定序盒等）
  • 依應用領域（腫瘤學、生殖醫學、臨床研究、農業基因體學/法醫學等）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章 北美定序試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲定序試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區定序試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲定序試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美定序試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球定序試劑市場：SWOT分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Thermo Fisher Scientific, Inc
• Abzena Ltd
• Illumina, Inc.
• QIAGEN NV
• Pacific Biosciences of California, Inc.
• F. Hoffmann-La Roche Ltd.
• Oxford Nanopore Technologies Plc.
• Agilent Technologies, Inc.
• Fluidigm Corporation
• Integrated DNA Technologies, Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Sequencing Reagents Market is projected to grow from USD 9.57 Billion in 2025 to USD 17.46 Billion by 2031, registering a CAGR of 10.54%. These reagents, comprising essential enzymes, chemical kits, and consumables, are critical for library preparation and nucleic acid analysis in research and clinical environments. The market is primarily driven by the rising prevalence of chronic diseases and the subsequent need for precision medicine reliant on accurate genomic profiling. For instance, the American Cancer Society estimates that 2,041,910 new cancer cases will occur in the United States in 2025, highlighting the urgent need for advanced diagnostic capabilities. This increasing disease burden mandates the continuous procurement of high-quality reagents for targeted therapy selection and mutation detection.

However, market expansion is hindered by the significant capital investment necessary to establish sequencing infrastructure. Many smaller laboratories and institutions, particularly in emerging economies, face difficulties with the high costs associated with acquiring and maintaining advanced sequencing platforms. This financial barrier directly limits their ability to purchase recurring reagent supplies, effectively restricting the addressable market. Consequently, the high cost of entry slows the global adoption of advanced sequencing technologies in resource-limited settings, reducing the overall potential for reagent consumption in these regions.

Market Driver

Technological advancements in next-generation sequencing platforms are a major force propelling the Global Sequencing Reagents Market. The deployment of high-throughput systems has lowered sequencing costs while increasing data output, creating a need for a larger volume of consumable kits for flow cell usage and library preparation. As laboratories shift to these high-capacity instruments to maximize efficiency, recurring revenue from the associated reagents has grown. For example, Oxford Nanopore Technologies reported in September 2025 that revenue from its PromethION product range rose to £51.1 million for the first half of the year. This growth illustrates how platform innovation stimulates the continuous consumption of specialized chemical reagents required for large-scale genomic operations.

Simultaneously, a surge in government initiatives and genomics research funding is accelerating market demand by facilitating large-scale population studies. Public and private investments are increasingly targeting pangenome references and precision medicine programs, which depend heavily on extensive sequencing workflows. In March 2025, Genome Canada launched the Canadian Precision Health Initiative with an $81 million investment to build a diverse genomic data resource. Additionally, News-Medical.Net reported in 2025 that Washington University School of Medicine received $14 million to renew the Human Pangenome Reference Sequencing Project. Such financial support allows research centers to procure the necessary consumables for thousands of samples, ensuring sustained market growth.

Market Challenge

The substantial capital investment required to establish sequencing infrastructure acts as a significant barrier to the expansion of the Global Sequencing Reagents Market. The high costs associated with acquiring genomic platforms effectively exclude smaller laboratories and research institutions in resource-constrained regions from entering the sector. Since reagent consumption is intrinsically linked to the installed base of sequencing instruments, the inability of these entities to surmount initial financial hurdles directly limits the volume of recurring sales. Without the budget to procure the necessary hardware, potential customers cannot generate demand for the associated chemical kits and consumables, thereby restricting the total addressable market.

This economic pressure is further exacerbated by contractions in research funding, which is a critical lifeline for capital equipment procurement in clinical and academic sectors. According to the Association of American Medical Colleges, the National Institutes of Health committed approximately $5 billion less in research grants to United States institutions in 2025 compared to the previous year. Such significant reductions in available capital constrain the purchasing power of laboratories, compelling them to defer infrastructure upgrades or expansion. Consequently, this stagnation in platform adoption creates a downstream bottleneck that severely hampers volume growth in the sequencing reagents sector.

Market Trends

The market is witnessing a decisive surge in demand for spatial genomics and single-cell consumables, driven by the critical need to resolve cellular heterogeneity often obscured by bulk sequencing. Researchers are increasingly adopting complex reagent kits capable of mapping gene expression directly to tissue architecture or barcoding individual cells, workflows that command a significantly higher price point per sample compared to standard library preparation. This shift toward high-resolution biological analysis is sustaining revenue growth in the reagents sector, even as capital equipment sales face volatility. For instance, 10x Genomics reported in January 2025 that consumables revenue reached approximately $493.4 million for the full year 2024, representing 3% growth over the prior year despite a challenging instrument sales environment.

Simultaneously, the development of specialized reagents for oncology profiling and liquid biopsy is creating a robust, high-volume sub-segment. Laboratories are actively procuring advanced chemistry sets designed for the ultra-sensitive detection of methylation patterns and circulating tumor DNA (ctDNA), which are essential for therapy monitoring and non-invasive cancer screening. These precision diagnostic workflows require highly optimized enrichment panels and enzymes to ensure accuracy, significantly increasing the frequency of recurring reagent orders from clinical providers. Underscoring this trend, Guardant Health reported in February 2025 that oncology clinical test volumes grew by 20% year-over-year to approximately 206,700 tests for the full year 2024, directly fueling the consumption of these specialized molecular diagnostics consumables.

Key Market Players

• Thermo Fisher Scientific, Inc
• Abzena Ltd
• Illumina, Inc.
• QIAGEN N.V.
• Pacific Biosciences of California, Inc.
• F. Hoffmann-La Roche Ltd.
• Oxford Nanopore Technologies Plc.
• Agilent Technologies, Inc.
• Fluidigm Corporation
• Integrated DNA Technologies, Inc

Report Scope

In this report, the Global Sequencing Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sequencing Reagents Market, By Technology

• Sanger Sequencing
• Next-Generation Sequencing
• Third Generation Sequencing

Sequencing Reagents Market, By Type

• Library Kits
• Template Kits
• Control Kits
• Sequencing Kits
• Others

Sequencing Reagents Market, By Application

• Oncology
• Reproductive Health
• Clinical Investigation
• Agrigenomics & Forensics
• Others

Sequencing Reagents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sequencing Reagents Market.

Available Customizations:

Global Sequencing Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sequencing Reagents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology (Sanger Sequencing, Next-Generation Sequencing, Third Generation Sequencing)
  • 5.2.2. By Type (Library Kits, Template Kits, Control Kits, Sequencing Kits, Others)
  • 5.2.3. By Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Sequencing Reagents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Sequencing Reagents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Sequencing Reagents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Sequencing Reagents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application

7. Europe Sequencing Reagents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Sequencing Reagents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
  • 7.3.2. France Sequencing Reagents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Sequencing Reagents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Sequencing Reagents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technology
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Sequencing Reagents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technology
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application

8. Asia Pacific Sequencing Reagents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Sequencing Reagents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
  • 8.3.2. India Sequencing Reagents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Sequencing Reagents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Sequencing Reagents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technology
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Sequencing Reagents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technology
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application

9. Middle East & Africa Sequencing Reagents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Sequencing Reagents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Sequencing Reagents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Sequencing Reagents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application

10. South America Sequencing Reagents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technology
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Sequencing Reagents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technology
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Sequencing Reagents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technology
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Sequencing Reagents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technology
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Sequencing Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific, Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abzena Ltd
• 15.3. Illumina, Inc.
• 15.4. QIAGEN N.V.
• 15.5. Pacific Biosciences of California, Inc.
• 15.6. F. Hoffmann-La Roche Ltd.
• 15.7. Oxford Nanopore Technologies Plc.
• 15.8. Agilent Technologies, Inc.
• 15.9. Fluidigm Corporation
• 15.10. Integrated DNA Technologies, Inc

16. Strategic Recommendations

17. About Us & Disclaimer